![Die Sha](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Die Sha
Directeur/Bestuurslid bij JIANGSU JIANGNAN WATER CO., LTD.
Profiel
Die Sha currently works as an Independent Director at Jiangsu Jiangnan Water Co., Ltd.
Ms. Sha has previously worked as an Independent Director at HLA Group Corp.
Ltd.
from 2020 to 2023, as well as a Director at Thousand Oaks Biologics, Inc. and an Independent Director at Jiangyin PIVOT.
Automotive Products Co., Ltd.
Actieve functies van Die Sha
Bedrijven | Functie | Begin |
---|---|---|
JIANGSU JIANGNAN WATER CO., LTD. | Directeur/Bestuurslid | 06-09-2018 |
Eerdere bekende functies van Die Sha
Bedrijven | Functie | Einde |
---|---|---|
HLA GROUP CORP., LTD. | Directeur/Bestuurslid | 19-05-2023 |
Thousand Oaks Biologics, Inc.
![]() Thousand Oaks Biologics, Inc. BiotechnologyHealth Technology Thousand Oaks Biologics, Inc. engages in the biopharmaceutical research and development in China, including process detection technology development and validation, process amplification, stability investigation, and pre-clinical to clinical phase sample cGMP standards. The company was founded on March 14, 2017 and is headquartered in Hainan, China. | Directeur/Bestuurslid | - |
JIANGYIN PIVOT AUTOMOTIVE PRODUCTS CO., LTD. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
JIANGSU JIANGNAN WATER CO., LTD. | Utilities |
JIANGYIN PIVOT AUTOMOTIVE PRODUCTS CO., LTD. | Producer Manufacturing |
HLA GROUP CORP., LTD. | Consumer Non-Durables |
Bedrijven in privébezit | 1 |
---|---|
Thousand Oaks Biologics, Inc.
![]() Thousand Oaks Biologics, Inc. BiotechnologyHealth Technology Thousand Oaks Biologics, Inc. engages in the biopharmaceutical research and development in China, including process detection technology development and validation, process amplification, stability investigation, and pre-clinical to clinical phase sample cGMP standards. The company was founded on March 14, 2017 and is headquartered in Hainan, China. | Health Technology |